Region-specific neuron and synapse loss in the hippocampus of APPSL/PS1 knock-in mice

Scheff S.W., Price D.A., Schmitt F.A., Scheff M.A., Mufson E.J., Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer’s disease, J. Alzheimers Dis., 2011, 24, 547–557 Selkoe D.J., Alzheimer’s disease is a synaptic failure, Science, 2002, 298, 789–791 Walsh D.M., Selkoe D.J., Deciphering the molecular basis of memory failure in Alzheimer’s disease, Neuron, 2004, 44, 181–193 Yu W., Lu B., Synapses and dendritic spines as pathogenic targets in Alzheimer’s disease, Neural Plast., 2012, 2012, 1–8 Tam J.H., Pasternak S.H., Amyloid and Alzheimer’s disease: inside and out, Can. J. Neurol. Sci., 2012, 39, 286–298 Luque F.A., Jaffe S.L., The molecular and cellular pathogenesis of dementia of the Alzheimer’s type an overview, Int. Rev. Neurobiol., 2009, 84, 151–165 Fjell A.M., Walhovd K.B., Neuroimaging results impose new views on Alzheimer’s disease-the role of amyloid revised, Mol. Neurobiol., 2012, 1–20 Hardy J., Selkoe D.J., The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics, Science, 2002, 297, 353–356 Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., et al., High-level neuronal expression of abeta 1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J. Neurosci., 2000, 20, 4050–4058 Klein W.L., Krafft G.A., Finch C.E., Targeting small Abeta oligomers: the solution to an Alzheimer’s disease conundrum?, Trends Neurosci., 2001, 24, 219–224 Schmitz C., Rutten B.P., Pielen A., Schafer S., Wirths O., Tremp G., et al., Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer’s disease, Am. J. Pathol., 2004, 164, 1495–1502 Boncristiano S., Calhoun M.E., Howard V., Bondolfi L., Kaeser S.A., Wiederhold K.H., et al., Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice, Neurobiol. Aging, 2005, 26, 607–613 Dickey C.A., Loring J.F., Montgomery J., Gordon M.N., Eastman P.S., Morgan D., Selectively reduced expression of synaptic plasticityrelated genes in amyloid precursor protein + presenilin-1 transgenic mice, J. Neurosci., 2003, 23, 5219–5226 Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., et al., Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models, Proc. Natl. Acad. Sci. USA, 1999, 96, 3228–3233 Rutten B.P., Van der Kolk N.M., Schafer S., van Zandvoort M.A., Bayer T.A., Steinbusch H.W., et al., Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice, Am. J. Pathol., 2005, 167, 161–173 West M.J., Bach G., Soderman A., Jensen J.L., Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice, Neurobiol. Aging, 2009, 30, 1756–1776 Nizzari M., Thellung S., Corsaro A., Villa V., Pagano A., Porcile C., et al., Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling, J. Toxicol., 2012, 2012, 1–13 Revett T.J., Baker G.B., Jhamandas J., Kar S., Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology, J. Psychiatry Neurosci., 2013, 38, 6–23 Casas C., Sergeant N., Itier J.M., Blanchard V., Wirths O., van der Kolk N., et al., Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model, Am. J. Pathol., 2004, 165, 1289–1300 Wirths O., Breyhan H., Schafer S., Roth C., Bayer T.A., Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer’s disease, Neurobiol. Aging, 2008, 29, 891–901 Wirths O., Weis J., Szczygielski J., Multhaup G., Bayer T.A., Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease, Acta Neuropathol., 2006, 111, 312–319 Takahashi H., Brasnjevic I., Rutten B.P., Van Der Kolk N., Perl D.P., Bouras C., et al., Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease, Brain Struct. Funct., 2010, 214, 145–160 Borchardt T., Camakaris J., Cappai R., Masters C.L., Beyreuther K., Multhaup G., Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursorprotein secretion, Biochem. J., 1999, 344, 461–467 Schmitz C., Hof P.R., Design-based stereology in neuroscience, Neuroscience, 2005, 130, 813–831 Franklin K., Paxinos G., The mouse brain in stereotaxic coordinates, Academic Press, San Diego, 1997 Van de Berg W.D., Blokland A., Cuello A.C., Schmitz C., Vreuls W., Steinbusch H.W., et al., Perinatal asphyxia results in changes in presynaptic bouton number in striatum and cerebral cortex-a stereological and behavioral analysis, J. Chem. Neuroanat., 2000, 20, 71–82 Heinonen O., Soininen H., Sorvari H., Kosunen O. Paljarvi L., Koivisto E., et al., Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer’s disease, Neuroscience, 1995, 64, 375–385 Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., et al., Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol, 1991, 30, 572–580 Ingelsson M., Fukumoto H., Newell K.L., Growdon J.H., Hedley-Whyte E.T., Frosch M.P., et al., Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain, Neurology, 2004, 62, 925–931 Clare R., King V.G., Wirenfeldt M., Vinters H.V., 2010, Synapse loss in dementias, J. Neurosci. Res., 88, 2083–2090 Cotel M.C., Bayer T.A., Wirths O., Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice, Brain Res., 2008, 1222, 207–213 Breyhan H., Wirths O., Duan K., Marcello A., Rettig J., Bayer T.A., APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy, Acta Neuropathol., 2009, 117, 677–685 Tomiyama T., Matsuyama S., Iso H., Umeda T., Takuma H., Ohnishi K., et al., A mouse model of amyloid β oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo, J. Neurosci., 2010, 30, 4845–4856 Sanchez-Varo R., Trujillo-Estrada L., Sanchez-Mejias E., Torres M., Baglietto-Vargas D., Moreno-Gonzalez I., et al., Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus, Acta Neuropathol., 2012, 1–18 Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., et al., Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse, J. Neurosci., 1997, 17, 7053–7059 Calhoun M.E., Wiederhold K.H., Abramowski D., Phinney A.L., Probst A., Sturchler-Pierrat C., et al., Neuron loss in APP transgenic mice, Nature, 1998, 395, 755–756 Takeuchi A., Irizarry M.C., Duff K., Saido T.C., Hsiao Ashe K., Hasegawa M., et al., Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss, Am. J. Pathol., 2000, 157, 331–339 Dickson D.W., Building a more perfect beast: APP transgenic mice with neuronal loss, Am. J. Pathol., 2004, 164, 1143–1146 Howlett D.R., Bowler K., Soden P.E., Riddell D., Davis J.B., Richardson J.C., et al., Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer’s disease, Histol. Histopathol., 2008, 23, 67–76 Van Broeck B., Vanhoutte G., Pirici D., Van Dam D., Wils H., Cuijt I., et al., Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer’s disease, Neurobiol. Aging, 2008, 29, 241–252 Elder G.A., Gama Sosa M.A., De Gasperi R., Dickstein D.L., Hof P.R., Presenilin transgenic mice as models of Alzheimer’s disease, Brain Struct. Funct., 2010, 214, 127–143 Mukaetova-Ladinska E.B., Garcia-Siera F., Hurt J., Gertz H.J., Xuereb J.H., Hills R., et al., Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer’s disease, Am. J. Pathol., 2000, 157, 623–636 Counts S.E., Nadeem M., Lad S.P., Wuu J., Mufson E.J., Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment, J. Neuropathol. Exp. Neurol., 2006, 65, 592–601 Bell K.F., Bennett D.A., Cuello A.C., Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment, J. Neurosci., 2007, 27, 10810–10817 Akram A., Christoffel D., Rocher A.B., Bouras C., Kovari E., Perl D.P., et al., Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer’s disease, Neurobiol. Aging, 2008, 29, 1296–1307 Bronfman F.C., Moechars D., Van Leuven F., Acetylcholinesterasepositive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice, Neurobiol. Dis., 2000, 7, 152–168 Briones T.L., Suh E., Jozsa L., Rogozinska M., Woods J., Wadowska M., Changes in number of synapses and mitochondria in presynaptic terminals in the dentate gyrus following cerebral ischemia and rehabilitation training, Brain Res., 2005, 1033, 51–57 DeKosky S.T., Scheff S.W., Styren S.D., Structural correlates of cognition in dementia: quantification and assessment of synapse change, Neurodegeneration, 1996, 5, 417–421 Seeger G., Gärtner U., Ueberham U., Rohn S., Arendt T., FAD-mutation of APP is associated with a loss of its synaptotrophic activity, Neurobiol. Dis., 2009, 35, 258–263 Dong H., Martin M.V., Chambers S., Csernansky J.G., Spatial relationship between synapse loss and β-amyloid deposition in Tg2576 mice, J. Comp. Neurol., 2006, 500, 311–321 Hu L., Wong T.P., Cote S.L., Bell K.F., Cuello A.C., The impact of Abetaplaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer’s disease-like transgenic mice, Neuroscience, 2003, 121, 421–432 Savage M.J., Lin Y.G., Ciallella J.R., Flood D.G., Scott R.W., Activation of c-Jun N-terminal kinase and p38 in an Alzheimer’s disease model is associated with amyloid deposition, J. Neurosci., 2002, 22, 3376–3385 Gruart A., Lopez-Ramos J.C., Munoz M.D., Delgado-Garcia J.M., Aged wild-type and APP, PS1, and APP + PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load, Neurobiol. Dis., 2008, 30, 439–450 Koo E.H., Kopan R., Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration, Nat. Med., 2004, Suppl. 10, S26–33 Morfini G., Pigino G., Beffert U., Busciglio J., Brady S.T., Fast axonal transport misregulation and Alzheimer’s disease, Neuromolecular Med., 2002, 2, 89–99 Gadadhar A., Marr R., Lazarov O., Presenilin-1 regulates neural progenitor cell differentiation in the adult brain, J. Neurosci., 2011, 31, 2615–2623 Lemmens M.A.M., Sierksma A.S.R., Rutten B.P.F., Dennissen F., Steinbusch H.W.M., Lucassen P.J., et al., Age-related changes of neuron numbers in the frontal cortex of a transgenic mouse model of Alzheimer’s disease, Brain Struct. Funct., 2011, 216, 227–237 van Tijn P., Kamphuis W., Marlatt M.W., Hol E.M., Lucassen P.J., Presenilin mouse and zebrafish models for dementia: focus on neurogenesis, Prog. Neurobiol., 2011, 93, 149–164